← Leaderboards
Roy Freeman
Beth Israel Deaconess Medical Center
$22,152,212
Attributed
$37,806,249
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.1M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$37,806,249 · 14
By mechanism
R01$15,574,960 · 5
RM1$11,100,837 · 1
UH3$7,081,684 · 1
U54$2,390,082 · 2
UG3$1,600,475 · 1
M01$58,211 · 4
Top collaborators
- Gail Kurr Adler5 shared
- David Borsook5 shared
- Robert R Edwards2 shared
- Jennifer Gewandter2 shared
- Marco Luciano Loggia2 shared
- Brian Jason Wainger2 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Andrew Tarulli$106,336
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseClinical ResearchBaroreflexCardiovascular SystemReportingStressHypoglycemiaWomanBlood GlucosePlacebosCardiovascular PhysiologyHuman SubjectEventSensoryPlayCardiacMorbidity - Disease RateFailure (Biologic Function)Diabetes MellitusBiological MarkersExposure ToAutonomic DysfunctionRandomizedMetabolic
Grant awards (49)
Sensory Phenotyping to Enhance Neuropathic Pain Drug Development$7,081,684
UH3 · FY2025 · NS · contact PI
From Nerve to Brain: Toward a Mechanistic Understanding of Spinal Cord Stimulation in Human Subjects$3,986,147
RM1 · FY2025 · NS
Sensory Phenotyping to Enhance Neuropathic Pain Drug Development$1,600,475
UG3 · FY2023 · NS · contact PI
The Functional Neuroanatomy of the Human Physiological Stress Response$728,359
R01 · FY2023 · NS · contact PI
From Nerve to Brain: Toward a Mechanistic Understanding of Spinal Cord Stimulation in Human Subjects$7,114,690
RM1 · FY2022 · NS
The functional neuroanatomy of the human physiological stress response$728,359
R01 · FY2022 · NS · contact PI
The functional neuroanatomy of the human physiological stress response$728,359
R01 · FY2021 · NS · contact PI
The functional neuroanatomy of the human physiological stress response$735,387
R01 · FY2020 · NS · contact PI
The functional neuroanatomy of the human physiological stress response$777,595
R01 · FY2019 · NS · contact PI
Project 4: Synucleinopathy Biomarkers and the Skin$252,643
U54 · FY2018 · NS · contact PI
Project 4: Synucleinopathy Biomarkers and the Skin$252,643
U54 · FY2017 · NS · contact PI
Hypoglycemia, Cardiovascular Autonomic Function and Type 2 Diabetes Mellitus$710,976
R01 · FY2016 · HL · contact PI
Project 4: Synucleinopathy Biomarkers and the Skin$252,643
U54 · FY2016 · NS · contact PI
Hypoglycemia, Cardiovascular Autonomic Function and Type 2 Diabetes Mellitus$700,310
R01 · FY2015 · HL · contact PI
Project 4: Synucleinopathy Biomarkers and the Skin$266,893
U54 · FY2015 · NS · contact PI
Hypoglycemia, Cardiovascular Autonomic Function and Type 2 Diabetes Mellitus$716,093
R01 · FY2014 · HL · contact PI
Hypoglycemia, mineralocorticoid receptor and autonomic control$510,353
R01 · FY2014 · HL · contact PI
Hypoglycemia, Cardiovascular Autonomic Function and Type 2 Diabetes Mellitus$719,645
R01 · FY2013 · HL · contact PI
Hypoglycemia, mineralocorticoid receptor and autonomic control$498,592
R01 · FY2013 · HL · contact PI
project 3 - Autonomic Rare Diseases Clinical Research Consortium$258,391
U54 · FY2013 · NS · contact PI
Hypoglycemia, mineralocorticoid receptor and autonomic control$546,638
R01 · FY2012 · HL · contact PI
project 3 - Autonomic Rare Diseases Clinical Research Consortium$282,078
U54 · FY2012 · NS · contact PI
Hypoglycemia, mineralocorticoid receptor and autonomic control$571,087
R01 · FY2011 · HL · contact PI
Orthostatic Intolerance in CFS$412,046
R01 · FY2011 · HL · contact PI
project 3 - Autonomic Rare Diseases Clinical Research Consortium$261,000
U54 · FY2011 · NS · contact PI
Orthostatic Intolerance in CFS$412,046
R01 · FY2010 · HL · contact PI
project 3 - Autonomic Rare Diseases Clinical Research Consortium$290,666
U54 · FY2010 · NS · contact PI
Orthostatic Intolerance in CFS$412,046
R01 · FY2009 · HL · contact PI
project 3 - Autonomic Rare Diseases Clinical Research Consortium$273,125
U54 · FY2009 · NS · contact PI
Orthostatic Intolerance in CFS$412,046
R01 · FY2008 · HL · contact PI
THE PATHOPHYSIOLOGY OF ORTHOSTATIC INTOLERANCE$1,618
M01 · FY2008 · RR · contact PI
HYPOGLYCEMIA AND AUTONOMIC NERVOUS SYSTEM FUNCTION$583,282
R01 · FY2007 · DK · contact PI
THE PATHOPHYSIOLOGY OF ORTHOSTATIC INTOLERANCE$33,468
M01 · FY2007 · RR · contact PI
HYPOGLYCEMIA AND AUTONOMIC NERVOUS SYSTEM FUNCTION$587,787
R01 · FY2006 · DK · contact PI
ORTHOSTATIC INTOLERANCE IN CFS$406,290
R01 · FY2006 · HL · contact PI
ORTHOSTATIC INTOLERANCE$23,125
M01 · FY2006 · RR · contact PI
HYPOGLYCEMIA AND AUTONOMIC NERVOUS SYSTEM FUNCTION$587,665
R01 · FY2005 · DK
ORTHOSTATIC INTOLERANCE IN CFS$403,952
R01 · FY2005 · HL
HYPOGLYCEMIA AND AUTONOMIC NERVOUS SYSTEM FUNCTION$573,818
R01 · FY2004 · DK
ORTHOSTATIC INTOLERANCE IN CFS$392,186
R01 · FY2004 · HL
HYPOGLYCEMIA AND AUTONOMIC NERVOUS SYSTEM FUNCTION$615,470
R01 · FY2003 · DK
ORTHOSTATIC INTOLERANCE IN CFS$452,661
R01 · FY2003 · HL
PATHOPHYSIOLOGY OF ORTHOSTATIC INTOLERANCE$0
M01 · FY2002 · RR
ORTHOSTATIC INTOLERANCE IN CFS$334,984
R01 · FY2001 · HL
PATHOPHYSIOLOGY OF ORTHOSTATIC INTOLERANCE$0
M01 · FY2001 · RR
ORTHOSTATIC INTOLERANCE IN CFS$316,928
R01 · FY2000 · HL
PATHOPHYSIOLOGY OF ORTHOSTATIC INTOLERANCE$0
M01 · FY2000 · RR
PATHOPHYSIOLOGY OF ORTHOSTATIC INTOLERANCE$0
M01 · FY2000 · RR
PATHOPHYSIOLOGY OF ORTHOSTATIC INTOLERANCE$0
M01 · FY2000 · RR